Diabetes, Obesity and Metabolism
| Discipline | Diabetology, endocrinology, metabolism, pharmacology |
|---|---|
| Language | English |
| Edited by | R. Donnelly, A. Garber |
| Publication details | |
| History | 1999–present |
| Publisher | |
| Frequency | Monthly |
| 5.4 (2023) | |
| Standard abbreviations | |
| ISO 4 | Diabetes Obes. Metab. |
| Indexing | |
| CODEN | DOMEF6 |
| ISSN | 1462-8902 (print) 1463-1326 (web) |
| LCCN | 00244962 |
| OCLC no. | 605132321 |
| Links | |
Diabetes, Obesity and Metabolism is a monthly peer-reviewed medical journal established in 1999 covering research on diabetes, obesity, and metabolism. The journal has a 2023 Clarivate impact factor of 5.4.[1]
The journal publishes on topics such as pharmacokinetics and pharmacodynamics, cost-effectiveness, real world evidence of drug utilisation, safety and effectiveness, as well as conventional randomized controlled trials (phase I-IV studies).